News

Sartorius Launches Expansion in South Korea with Mullti-Million Dollar Investment

December 02, 2021

Sartorius will invest approximately €270 million (US$305 million) to expand its biopharmaceutical manufacturing activities in South Korea’s biopharm hub.

The Key Elements for Assay Transfer Success

December 02, 2021

Partnerships formed during the COVID-19 pandemic have provided a platform for change in assay development and transfers that should continue in the future.

Spinning Success? The Benefits of University Spinouts

December 02, 2021

Pharma and biotech are ruling the roost in terms of university innovation, but European spinouts are still experiencing barriers to long-term success.

Pandemic Alters Policies and Practices for Drug Development and Regulation

December 02, 2021

The need for medicines to combat COVID-19 has impacted the way regulatory agencies carry out their operations.

Breaking the Rules

December 02, 2021

We have broken rules, invented new ones, and engineered stronger institutions and supply chains that will serve us better going forward.

CordenPharma Adds Highly Potent Capabilities in Germany

December 01, 2021

CordenPharma will build a clinical trial development facility for manufacture of oral solid dosage drug products at its Plankstadt facility near Heidelberg, Germany.

New Carbon Nanotube-Based Sensor Can Detect SARS-CoV-2 Proteins

November 30, 2021

Researchers from MIT have developed novel nanosensors for the detection of the nucleocapsid and spike protein of the SARS-CoV-2 virus.

Novozymes and Novo Nordisk Pharmatech Collaborate on Enzymes for Biopharma Production

November 29, 2021

Novozymes and Novo Nordisk Pharmatech are teaming up to develop best-in-class technical enzymes to support biopharmaceutical production processes.

BeiGene Acquires Property in New Jersey to Build Manufacturing and Clinical R&D Center

November 29, 2021

BeiGene has acquired property in Hopewell, NJ to build a new manufacturing site and clinical R&D center for advanced new medicines.

Samsung Biologics, GreenLight Biosciences, and Environmental Impact Acquisition Corp to Build mRNA Vaccine Manufacturing Capacity

November 29, 2021

Samsung Biologics, GreenLight Biosciences, and Environmental Impact Acquisition Corp. have partnered to advance GreenLight’s mRNA COVID-19 vaccine candidate.